Home › Glioma › North Carolina › Durham
Glioma clinical trials in Durham, NC
12 studies for Glioma are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RecruitingPhase 2
- Duke University Medical Center, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Duke Cancer Institute, Durham
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Duke University Health System, Durham
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
RecruitingPhase 1
- Duke University Medical Center, Durham
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Duke Cancer Center, Durham
Lerapolturev (PVSRIPO) in GBM
RecruitingPhase 2
- Duke University Medical Center, Durham
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
RecruitingPhase 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Duke University Health System, Durham
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
RecruitingPhase 1
- Duke University, Durham
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RecruitingEarly phase 1
- Duke University Health System, Durham
Glioma trials in other cities
- New York City, NY26 studies
- Houston, TX24 studies
- Boston, MA19 studies
- Washington, DC17 studies
- Philadelphia, PA15 studies
- Columbus, OH15 studies
- San Francisco, CA15 studies
- Miami, FL15 studies
- Chicago, IL12 studies
- Los Angeles, CA11 studies
- Aurora, CO10 studies
- Seattle, WA10 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)61 studies
- Non-Small Cell Lung Cancer42 studies
- Multiple Myeloma36 studies
- Acute Myeloid Leukemia34 studies
- Lung Cancer33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Colorectal Cancer30 studies
- Ovarian Cancer28 studies
- Chronic Lymphocytic Leukemia28 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.